New chelating agents suitable for the treatment of iron overload

Inorganica Chimica Acta

Volumn 291, Issue 1-2, 1999, Pages 238-246

  Martell, Arthur E ^a   Motekaitis, R J ^a   Sun, Y ^a   Ma, R ^a   Welch, M J ^b   Pajeau, T ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chelating agents; Cooley's anemia; Iron overload

Indexed keywords

BIOCHEMISTRY; CHELATION; LIGANDS; ORGANIC LIGHT EMITTING DIODES (OLED); TOXICITY;

ANIMAL TESTS; CHELATING AGENT; CLINICAL TRIAL; COOLEY'S ANEMIA; ETHYLENE DIAMINE; HIGH AFFINITY; IRON OVERLOADS; SCREENING TESTS;

IRON COMPOUNDS;

EID: 0000147495     PISSN: 00201693     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0020-1693(99)00126-7     Document Type: Article

References (54)

1. L.L. Ingrham, D.L. Meyer, Biochemistry of Dioxygen, Plenum, New York, pp. 121-138.
2. Hider R.C., Hall A.D. Hay R.W., Dilworth J.R., Holan K.B. Perspectives on Bioinorganic Chemistry. 1:1991;209-253 JAI Press, Greenwich, CT.
3. D.J. Weatherall, J.B. Clegg, The Thalassemia Syndromes, 3rd ed., Blackwell Scientific Publications, Oxford.
4. Weatherall D.J. Martell A.E., Anderson W.F., Badman D.B. Development of Iron Chelators for Clinical Use. 1981;1-12 Elsevier, North Holland.
5. Jacobs A.J. Martell A.E., Anderson W.F., Badman D.B. Development of Iron Chelators for Clinical Use. 1981;29-46 Elsevier, North Holland.
6. Grady W.R., Jacobs A. Martell A.E., Anderson W.F., Badman D.B. Development of Iron Chelators for Clinical Use. 1981;134-164 Elsevier, North Holland.
7. Porter J.B., Huehns E.R., Hider R.C. Hershko C. Baillieres Clinical Haematology. 2:1989;Bailliere Tindall, London.
8. Koren G., Bentur Y., Strong D., Harvey E., Klein J., Baumal R., Spielberg S.P., Freedman M.H. Am. J. Dis. Child. 143:1989;1077.
9. Martell A.E., Motekaitis R.J., Murase I., Sala L.F., Stoldt R., Ng C.Y., Rosenkrantz H., Metterville J.J. Inorg. Chim. Acta. 138:1987;215.
10. Martell A.E. Martell A.E., Badman D.G., Anderson W.F. Development of Iron Chelators for Clinical Use. 1981;67-104 Elsevier, North Holland.
11. Grady W.R. et al. Bergeron R.J., Brittenham G.M. The Development of Iron Chelators for Clinical Use. 1993;395-406 CRC Press, Boca Raton, FL.
12. W.R. Grady, 5th International Conference on Iron Chelation in the Treatment of Thalassemia and Other Diseases, University of Milan, November 12-13, 1993.
13. G. Kontoghiorghes, The Design of Orally Active Iron Chelators for the Treatment of Thalassemia, Ph.D. Thesis, University of Essex, June, 1982.
14. R.C. Hider, G.J. Kontoghiorghes, J. Silver, Br. Patent GB 2 136 807, 1984, 17 pp.
15. R.C. Hider, G.J. Kontoghiorghes, J. Silver, M.A. Stockton, Patent GB 2 136 806, 1984, 19 pp.
16. G.J. Kontoghiorghes, Lancet (1985) 817.
17. Kontoghiorghes G.J., Hoffbrand A.V. Br. J. Haematol. 62:1986;607.
18. Kontoghiorghes G.J. Mol. Pharmacol. 30:1986;670.
19. Kontoghiorghes G.J., Sheppard L., Chambers S. Arzneim. Forsch. 37:1987;1099.
20. Brock J.H., Liceaga J., Arthur H.M.L., Kontoghiorghes G.J. Am. J. Hematol. 34:1990;21.
21. Huehns E.R., Porter J.B., Hider R.C. Hemoglobin. 12:1989;593.
22. Porter J.B., Gyparaki M., Burke L.C., Huehns E.R., Sarpong P., Saez V., Hider R.C. Blood. 72:1988;1497.
23. Porter J.B., Morgan J., Hoyes K.P., Burke L.C., Huehns E.R., Hider R.C. Blood. 76:1990;2389.
24. Gyparaki M., Porter J.B., Streater M., Hider R.C., Huehns E.R. Acta Haematol. 78:1987;217.
25. P.S. Dobbin, R.C. Hider, Chem. Br. (1990) 565.
26. J.B. Porter, K.P. Hoyes, R. Abeysinghe, E.R. Huehns, R.C. Hider, Lancet II (1989) 156.
27. Motekaitis R.J., Martell A.E. Inorg. Chim. Acta. 183:1991;71.
28. Clarke E.T., Martell A.E. Inorg. Chim. Acta. 191:1992;57.
29. Clarke E.T., Martell A.E., Reibenspies J. Inorg. Chim. Acta. 196:1992;177.
30. Clarke E.T., Martell A.E. Inorg. Chim. Acta. 196:1992;185.
31. Ma R., Martell A.E. Inorg. Chim. Acta. 223:1994;21. and references therein.
32. Ma R., Martell A.E. Inorg. Chim. Acta. 224:1994;151.
33. Ma R., Martell A.E. Inorg. Chim. Acta. 209:1993;71.
34. Ma R., Motekaitis R.J., Martell A.E. Inorg. Chim. Acta. 233:1995;137.
35. A.E. Martell, R.J. Motekaitis, M.J. Welch, J. Chem. Soc., Chem. Commun. (1990) 1748.
36. Sun Y., Martell A.E., Reibenspies J., Welch M.J. Tetrahedron. 47(13):1991;364.
37. Motekaitis R.J., Sun Y., Martell A.E. Inorg. Chim. Acta. 198:1992;421.
38. Sun Y., Martell A.E., Welch M.J. Tetrahedron. 47:1991;8863.
39. Jones-Wilson T.M., Motekaitis R.J., Sun Y., Anderson C.J., Martell A.E., Welch M.J. Nucl. Med. Biol. 22(7):1995;859.
40. Sun Y., Motekaitis R.J., Martell A.E. Inorg. Chim. Acta. 281:1998;60.
41. Moore D.A., Fanwick P.E., Welch M.J. Inorg. Chem. 28:1989;1504.
42. Clarke E.T., Martell A.E. Inorg. Chim. Acta. 186:1991;103.
43. Streater M., Taylor P.D., Hider R.C., Porter J. J. Med. Chem. 33:1990;1749.
44. Scarrow R.C., Riley P.E., Abu-Dari K., White D.L., Raymond K.N. Inorg. Chem. 24:1985;954.
45. Martell A.E., Motekaitis R.J., Sun Y., Martell A.E. Bergeron R.J., Brittenham G.M. The Development of Iron Chelators for Clinical Use. 1993;329-351 CRC Press, Boca Raton, FL.
46. Sun Y., Martell A.E. J. Am. Chem. Soc. 111:1989;8023.
47. Sun Y., Martell A.E. Tetrahedron. 46:1990;2725.
48. Motekaitis R.J., Sun Y., Martell A.E. Inorg. Chem. 30:1991;1554.
49. MacMillan D.R., Murase I., Martell A.E. Inorg. Chem. 14:1975;468.
50. Sun Y., Motekaitis R.J., Martell A.E., Welch M.J. Inorg. Chim. Acta. 228:1995;77.
51. Moore D.A., Fanwick P.E., Welch M.J. Inorg. Chem. 29:1990;672.
52. Ma R., Welch M.J., Reibenspies J., Martell A.E. Inorg. Chim. Acta. 236:1995;75.
53. Peter H.H., Bergeron R.J., Streiff R.R., Wiegard J. Bergeron R.J., Brittenham G.M. The Development of Iron Chelators for Clinical Use. 1993;373-394 CRC Press, Boca Raton, FL. and references therein.
54. G. Anderegg, M. Raber, J. Chem. Soc., Chem. Commun. (1990) 1195.